Dr. Gabrail Nashat, MD

Gabrail Cancer Center ResearchDover, Ohio - 44622 (330-492-3345) |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2009

A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
November 2009 - April 2011
Lymphoma
Lymphoma, Mantle-Cell
P276-00



